CytoGenix Announces Completion of synDNA™ Production Module Prototype
Complete the form below to unlock access to ALL audio articles.
CytoGenix, Inc. has announced that the prototype version of the synDNA™ production module was completed on schedule.
The device was designed for the commercial production of cell-free DNA by the leading international biopharmaceutical plant design, engineering and construction firm of Alfa Laval Biokinetics, Philadelphia, Pennsylvania.
It was tested by Alfa Laval engineers and CytoGenix senior scientists. The final version will be mounted on a stainless steel cart and have the capacity to produce up to 10 grams of high-purity DNA in 24 hours.
Kurt Berens, CytoGenix, Inc. Vice President of Product Development, commented, "This is an important step in our overall plan to construct a cGMP manufacturing facility."
"We plan to install several synDNA™ production modules to meet the growing demand for clinical-grade DNA internally and from customers."
